131 related articles for article (PubMed ID: 37530345)
21. Bystander LECT2 amyloidosis in tumor nephrectomy.
Gallan AJ; Bhasin-Chhabra B; Kilari D; Johnson S; D'Souza A
CEN Case Rep; 2023 Feb; 12(1):104-109. PubMed ID: 35986199
[TBL] [Abstract][Full Text] [Related]
22. Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior.
Jamal M; Taneja K; Arora S; Barod R; Rogers CG; Sanchez J; Gupta NS; Williamson SR
Int J Surg Pathol; 2018 Sep; 26(6):536-541. PubMed ID: 29560759
[TBL] [Abstract][Full Text] [Related]
23. Compensatory Changes in Parenchymal Mass and Function after Radical Nephrectomy.
Aguilar Palacios D; Caraballo ER; Tanaka H; Wang Y; Suk-Ouichai C; Ye Y; Lin L; Li J; Abouassaly R; Campbell SC
J Urol; 2020 Jul; 204(1):42-49. PubMed ID: 32073996
[TBL] [Abstract][Full Text] [Related]
24. Effects of metabolic syndrome on renal function after radical nephrectomy in patients with renal cell carcinoma.
Zhang Y; Wu T; Xie J; Yan L; Guo X; Xu W; Wang L
Int Urol Nephrol; 2021 Oct; 53(10):2127-2135. PubMed ID: 33459957
[TBL] [Abstract][Full Text] [Related]
25. [Primary renal plasmacytoma. A case report].
Manseck A; Flössel C; Günther H; Wirth M
Urologe A; 1997 Jul; 36(4):369-73. PubMed ID: 9340906
[TBL] [Abstract][Full Text] [Related]
26. [Synchronous bilateral chromophobe cell renal carcinoma: a case report].
Mukai M; Imamura R; Takayama H; Nishimura K; Nonomura N; Okuyama A
Hinyokika Kiyo; 2009 Sep; 55(9):567-9. PubMed ID: 19827620
[TBL] [Abstract][Full Text] [Related]
27. [Bilateral kidney tumor. Therapy management and histopathological results with long-term follow-up of 66 patients].
Siemer S; Uder M; Zell A; Pönicke C; Humke U; Ziegler M; Stöckle M
Urologe A; 2001 Mar; 40(2):114-20. PubMed ID: 11315585
[TBL] [Abstract][Full Text] [Related]
28. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
29. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
[TBL] [Abstract][Full Text] [Related]
30. Histopathologic analysis of tumor bed and peritumoral pseudocapsule after in vitro tumor enucleation on radical nephrectomy specimen for clinical T1b renal cell carcinoma.
Lu Q; Ji C; Zhao X; Fu Y; Guo S; Liu G; Zhang S; Li X; Gan W; Guo H
Urol Oncol; 2017 Oct; 35(10):603.e15-603.e20. PubMed ID: 28619631
[TBL] [Abstract][Full Text] [Related]
31. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of nontumoral renal pathologies in tumor nephrectomies: nontumoral renal parenchyma changes.
Sarsık B; Simşir A; Yılmaz M; Yörükoğlu K; Sen S
Ann Diagn Pathol; 2013 Apr; 17(2):176-82. PubMed ID: 23142019
[TBL] [Abstract][Full Text] [Related]
34. Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes.
Harlow BL; Klaassen Z; Holzman S; Reinstatler L; Franken AA; Kavuri SK; Terris MK; Master VA; Moses KA
Clin Genitourin Cancer; 2016 Apr; 14(2):e171-5. PubMed ID: 26613833
[TBL] [Abstract][Full Text] [Related]
35. [Renal clear-cell adenocarcinoma and type B lymphomatous proliferation: a fortuitous association?].
Kurtz JE; Andrès E; Maloisel F; Herbrecht R; Dufour P
Rev Med Interne; 1999 Apr; 20(4):329-32. PubMed ID: 10327476
[TBL] [Abstract][Full Text] [Related]
36. An intracapsular nephrectomy for the acquired cystic disease-associated renal cell carcinoma in renal transplant allograft: A clinical case report.
Song Y; Zheng J; Guo S; Fan L
Medicine (Baltimore); 2021 May; 100(19):e25858. PubMed ID: 34106631
[TBL] [Abstract][Full Text] [Related]
37. Renal cell carcinoma in a horse-shoe kidney.
Kumar S; Gupta A; Bansal P; Tiwari P; Kundu AK
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1147-8. PubMed ID: 21060194
[No Abstract] [Full Text] [Related]
38. Histopathological characteristics of adult renal tumours: a preliminary report.
Latif F; Mubarak M; Kazi JI
J Pak Med Assoc; 2011 Mar; 61(3):224-8. PubMed ID: 21465932
[TBL] [Abstract][Full Text] [Related]
39. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein.
Woldu SL; Barlow LJ; Patel T; Hruby GW; Benson MC; McKiernan JM
Urology; 2010 Sep; 76(3):639-42. PubMed ID: 20163841
[TBL] [Abstract][Full Text] [Related]
40. Partial nephrectomy in a patient with dwarfism.
Farber NJ; Dubin J; Parihar J; Han C; Lasser MS
Can J Urol; 2016 Aug; 23(4):8375-8. PubMed ID: 27544562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
